Good Manufacturing Practice-Compliant Production and Lot-Release of Ex Vivo Expanded Regulatory T Cells As Basis for Treatment of Patients with Autoimmune and Inflammatory Disorders
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Good Manufacturing Practice-Compliant Production and Lot-Release of Ex Vivo Expanded Regulatory T Cells As Basis for Treatment of Patients with Autoimmune and Inflammatory Disorders
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-10-26
DOI
10.3389/fimmu.2017.01371
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative Colitis
- (2017) Caroline J. Voskens et al. INFLAMMATORY BOWEL DISEASES
- A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation
- (2016) Satoru Todo et al. HEPATOLOGY
- Successful expansion of functional and stable regulatory T cells for immunotherapy in liver transplantation
- (2016) Niloufar Safinia et al. Oncotarget
- Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect
- (2015) C. G. Brunstein et al. BLOOD
- Differential effects of α4β7 and GPR15 on homing of effector and regulatory T cells from patients with UC to the inflamed gut in vivo
- (2015) Anika Fischer et al. GUT
- Type 1 diabetes immunotherapy using polyclonal regulatory T cells
- (2015) Jeffrey A. Bluestone et al. Science Translational Medicine
- Freeze and Thaw of CD4+CD25+Foxp3+ Regulatory T Cells Results in Loss of CD62L Expression and a Reduced Capacity to Protect against Graft-versus-Host Disease
- (2015) Mareike Florek et al. PLoS One
- HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse
- (2014) M. F. Martelli et al. BLOOD
- Therapy of type 1 diabetes with CD4+CD25highCD127-regulatory T cells prolongs survival of pancreatic islets — Results of one year follow-up
- (2014) Natalia Marek-Trzonkowska et al. CLINICAL IMMUNOLOGY
- CXCR3+CCR5+ T cells and autoimmune diseases: guilty as charged?
- (2014) Charles R. Mackay JOURNAL OF CLINICAL INVESTIGATION
- Regulatory T Cells as Immunotherapy
- (2014) Benjamin D. Singer et al. Frontiers in Immunology
- Challenges in cryopreservation of regulatory T cells (Tregs) for clinical therapeutic applications
- (2013) Karolina Golab et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn's Disease
- (2012) Pierre Desreumaux et al. GASTROENTEROLOGY
- Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
- (2011) M. Di Ianni et al. BLOOD
- Regulatory T cells and Foxp3
- (2011) Alexander Y. Rudensky IMMUNOLOGICAL REVIEWS
- Regulatory T cells expanded by rapamycin in vitro suppress colitis in an experimental mouse model
- (2011) Haruei Ogino et al. JOURNAL OF GASTROENTEROLOGY
- Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics
- (2010) C. G. Brunstein et al. BLOOD
- Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice
- (2010) Michio Tomura et al. JOURNAL OF CLINICAL INVESTIGATION
- First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells
- (2009) Piotr Trzonkowski et al. CLINICAL IMMUNOLOGY
- Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor?
- (2009) Maria A. Curotto de Lafaille et al. IMMUNITY
- Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function
- (2009) Maciej Kmieciak et al. Journal of Translational Medicine
- Ex vivo expansion of CD4+CD25+T regulatory cells for immunosuppressive therapy
- (2008) Piotr Trzonkowski et al. CYTOMETRY PART A
- Epigenetic inheritance of DNA methylation limits activation-induced expression of FOXP3 in conventional human CD25-CD4+ T cells
- (2008) M. Nagar et al. INTERNATIONAL IMMUNOLOGY
- Clinical Grade Treg: GMP Isolation, Improvement of Purity by CD127pos Depletion, Treg Expansion, and Treg Cryopreservation
- (2008) Jorieke H. Peters et al. PLoS One
- Natural and TGF-β–induced Foxp3+CD4+ CD25+ regulatory T cells are not mirror images of each other
- (2008) David A. Horwitz et al. TRENDS IN IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started